Loading...
ESA, Iron Therapy and New Drugs: Are There New Perspectives in the Treatment of Anaemia?
Anemia is a well-known consequence of chronic kidney disease (CKD); it is mainly due to a relative insufficiency of erythropoietin synthesis by the failing kidneys. Over the years, the combination of erythropoiesis stimulating agents (ESA) and iron has become the standard of care of anemia. All ESAs...
Na minha lista:
| Udgivet i: | J Clin Med |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7922992/ https://ncbi.nlm.nih.gov/pubmed/33670704 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10040839 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|